Study of Lymphoedema and Urinary Issues After Pelvic Lymph Node Surgery for Urogenital Cancer

What this Trial Is About

Researchers are investigating the development of lower limb lymphoedema and urinary issues such as nocturia and nocturnal polyuria in patients treated for urogenital cancers like prostate and bladder cancer. This prospective observational study aims to determine how often these conditions occur after pelvic lymph node dissection surgery and to identify factors that may predict their development. The study also seeks to find the best clinical methods to detect early lymphoedema in the legs after treatment. The study involves 150 patients scheduled for transperitoneal pelvic lymph node dissection for urogenital cancer. Participants will be followed from before surgery until one year after surgery. All receive standard care including education about lymphoedema prevention, skincare routines, and supervised exercises to improve circulation, with frequency of therapy sessions decreasing over time. If lymphoedema develops, compression stockings will be provided. Evaluations occur at baseline, 6 weeks, 6 months, and 12 months post-surgery. During the study, participants will undergo clinical assessments for lymphoedema and urinary symptoms at scheduled visits. Researchers will track the incidence and prevalence of lymphoedema, as well as its detection methods, validity, and reliability. They will also study prognostic factors for lymphoedema and urinary conditions, monitoring changes over time. The study lasts up to two years, with participants enrolled during the first year and followed for one year after their surgery.

Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer